Search research articles
Contact Us
Filters
Showing results (911-920 of 933) with videos related to
Page
of 94
Sort By:
British Journal of Cancer
|
June 20, 2020
Clinical and pathological associations of PTEN expression in ovarian cancer: a multicentre study from the Ovarian Tumour Tissue Analysis Consortium
Filipe Correia Martins, Dominique-Laurent Couturier, Anna Paterson, et al.
Lancet (London, England)
|
May 15, 2018
International validation of the consensus Immunoscore for the classification of colon cancer: a prognostic and accuracy study
Franck Pagès, Bernhard Mlecnik, Florence Marliot, et al.
JAMA Oncology
|
October 20, 2017
Dose-Response Association of CD8+ Tumor-Infiltrating Lymphocytes and Survival Time in High-Grade Serous Ovarian Cancer
, Ellen L Goode, Matthew S Block, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
June 5, 2024
Concurrent RB1 Loss and BRCA Deficiency Predicts Enhanced Immunologic Response and Long-term Survival in Tubo-ovarian High-grade Serous Carcinoma
Flurina A M Saner, Kazuaki Takahashi, Timothy Budden, et al.
Carcinogenesis
|
December 12, 2013
Genome-wide association study identifies 25 known breast cancer susceptibility loci as risk factors for triple-negative breast cancer
Kristen S Purrington, Susan Slager, Diana Eccles, et al.
Medrxiv : the Preprint Server for Health Sciences
|
November 21, 2023
Concurrent RB1 loss and <i>BRCA</i>-deficiency predicts enhanced immunological response and long-term survival in tubo-ovarian high-grade serous carcinoma
Flurina A M Saner, Kazuaki Takahashi, Timothy Budden, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
October 12, 2022
Gene-Expression Profiling of Mucinous Ovarian Tumors and Comparison with Upper and Lower Gastrointestinal Tumors Identifies Markers Associated with Adverse Outcomes
Nicola S Meagher, Kylie L Gorringe, Matthew Wakefield, et al.
The Journal of Pathology. Clinical Research
|
March 22, 2023
p53 and ovarian carcinoma survival: an Ovarian Tumor Tissue Analysis consortium study
Martin Köbel, Eun-Young Kang, Ashley Weir, et al.
European Urology
|
November 23, 2019
EAU-ESMO Consensus Statements on the Management of Advanced and Variant Bladder Cancer-An International Collaborative Multistakeholder Effort<sup>†</sup>: Under the Auspices of the EAU-ESMO Guidelines Committees
J Alfred Witjes, Marek Babjuk, Joaquim Bellmunt, et al.
Virchows Archiv : an International Journal of Pathology
|
November 16, 2021
MCM3 is a novel proliferation marker associated with longer survival for patients with tubo-ovarian high-grade serous carcinoma
Eun Young Kang, Joshua Millstein, Gordana Popovic, et al.
Page
of 94
Search research articles
Search
Showing results (911-920 of 933) with videos related to
Sort By:
Page
of 94
British Journal of Cancer
|
June 20, 2020
Clinical and pathological associations of PTEN expression in ovarian cancer: a multicentre study from the Ovarian Tumour Tissue Analysis Consortium
Filipe Correia Martins, Dominique-Laurent Couturier, Anna Paterson, et al.
Lancet (London, England)
|
May 15, 2018
International validation of the consensus Immunoscore for the classification of colon cancer: a prognostic and accuracy study
Franck Pagès, Bernhard Mlecnik, Florence Marliot, et al.
JAMA Oncology
|
October 20, 2017
Dose-Response Association of CD8+ Tumor-Infiltrating Lymphocytes and Survival Time in High-Grade Serous Ovarian Cancer
, Ellen L Goode, Matthew S Block, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
June 5, 2024
Concurrent RB1 Loss and BRCA Deficiency Predicts Enhanced Immunologic Response and Long-term Survival in Tubo-ovarian High-grade Serous Carcinoma
Flurina A M Saner, Kazuaki Takahashi, Timothy Budden, et al.
Carcinogenesis
|
December 12, 2013
Genome-wide association study identifies 25 known breast cancer susceptibility loci as risk factors for triple-negative breast cancer
Kristen S Purrington, Susan Slager, Diana Eccles, et al.
Medrxiv : the Preprint Server for Health Sciences
|
November 21, 2023
Concurrent RB1 loss and <i>BRCA</i>-deficiency predicts enhanced immunological response and long-term survival in tubo-ovarian high-grade serous carcinoma
Flurina A M Saner, Kazuaki Takahashi, Timothy Budden, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
October 12, 2022
Gene-Expression Profiling of Mucinous Ovarian Tumors and Comparison with Upper and Lower Gastrointestinal Tumors Identifies Markers Associated with Adverse Outcomes
Nicola S Meagher, Kylie L Gorringe, Matthew Wakefield, et al.
The Journal of Pathology. Clinical Research
|
March 22, 2023
p53 and ovarian carcinoma survival: an Ovarian Tumor Tissue Analysis consortium study
Martin Köbel, Eun-Young Kang, Ashley Weir, et al.
European Urology
|
November 23, 2019
EAU-ESMO Consensus Statements on the Management of Advanced and Variant Bladder Cancer-An International Collaborative Multistakeholder Effort<sup>†</sup>: Under the Auspices of the EAU-ESMO Guidelines Committees
J Alfred Witjes, Marek Babjuk, Joaquim Bellmunt, et al.
Virchows Archiv : an International Journal of Pathology
|
November 16, 2021
MCM3 is a novel proliferation marker associated with longer survival for patients with tubo-ovarian high-grade serous carcinoma
Eun Young Kang, Joshua Millstein, Gordana Popovic, et al.
Page
of 94